Literature DB >> 19362631

Molecular classification of neoplasms of the pancreas.

Ralph H Hruban1, N Volkan Adsay.   

Abstract

The recent sequencing of the pancreatic cancer genome provides unprecedented insight into the fundamental nature of this deadly malignancy. Although much work still needs to be done, a molecular classification of neoplasms of the pancreas is emerging. Molecular genetics have been used to identify unique clinical subtypes of pancreatic cancer, to guide the clinical diagnosis of pancreatic tumors, and to identify targeted therapies for select pancreatic neoplasms. This review examines the emerging molecular classification of neoplasms of the pancreas. This classification does not ignore previous histology-based classification systems but instead embraces them, creating an integrated histological-molecular classification.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19362631     DOI: 10.1016/j.humpath.2009.01.008

Source DB:  PubMed          Journal:  Hum Pathol        ISSN: 0046-8177            Impact factor:   3.466


  30 in total

Review 1.  Molecular signatures of pancreatic cancer.

Authors:  Seung-Mo Hong; Jason Y Park; Ralph H Hruban; Michael Goggins
Journal:  Arch Pathol Lab Med       Date:  2011-06       Impact factor: 5.534

2.  Identification of blood-protein carriers of the CA 19-9 antigen and characterization of prevalence in pancreatic diseases.

Authors:  Tingting Yue; Katie Partyka; Kevin A Maupin; Mary Hurley; Philip Andrews; Karen Kaul; A James Moser; Herbert Zeh; Randall E Brand; Brian B Haab
Journal:  Proteomics       Date:  2011-08-02       Impact factor: 3.984

Review 3.  Polycomb and the emerging epigenetics of pancreatic cancer.

Authors:  Adrienne Grzenda; Tamas Ordog; Raul Urrutia
Journal:  J Gastrointest Cancer       Date:  2011-06

4.  The concept of 'borderline resectable' pancreatic cancer: limited foundations and limited future?

Authors:  John A Windsor; Savio George Barreto
Journal:  J Gastrointest Oncol       Date:  2017-02

Review 5.  Intraductal papillary mucinous neoplasms of the pancreas--a surgical disease.

Authors:  Jens Werner; Stefan Fritz; Markus W Büchler
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2012-03-06       Impact factor: 46.802

6.  Pancreatitis-induced inflammation contributes to pancreatic cancer by inhibiting oncogene-induced senescence.

Authors:  Carmen Guerra; Manuel Collado; Carolina Navas; Alberto J Schuhmacher; Isabel Hernández-Porras; Marta Cañamero; Manuel Rodriguez-Justo; Manuel Serrano; Mariano Barbacid
Journal:  Cancer Cell       Date:  2011-06-14       Impact factor: 31.743

7.  The expression of the receptor for advanced glycation endproducts (RAGE) is permissive for early pancreatic neoplasia.

Authors:  Rui Kang; Tara Loux; Daolin Tang; Nicole E Schapiro; Philip Vernon; Kristen M Livesey; Alyssa Krasinskas; Michael T Lotze; Herbert J Zeh
Journal:  Proc Natl Acad Sci U S A       Date:  2012-04-16       Impact factor: 11.205

8.  Glycogene expression alterations associated with pancreatic cancer epithelial-mesenchymal transition in complementary model systems.

Authors:  Kevin A Maupin; Arkadeep Sinha; Emily Eugster; Jeremy Miller; Julianna Ross; Vincent Paulino; Venkateshwar G Keshamouni; Nhan Tran; Michael Berens; Craig Webb; Brian B Haab
Journal:  PLoS One       Date:  2010-09-27       Impact factor: 3.240

9.  Smad4 inhibits cell migration via suppression of JNK activity in human pancreatic carcinoma PANC-1 cells.

Authors:  Xueying Zhang; Junxia Cao; Yujun Pei; Jiyan Zhang; Qingyang Wang
Journal:  Oncol Lett       Date:  2016-04-07       Impact factor: 2.967

Review 10.  Smad4-mediated TGF-beta signaling in tumorigenesis.

Authors:  Guan Yang; Xiao Yang
Journal:  Int J Biol Sci       Date:  2010-01-01       Impact factor: 6.580

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.